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Upper aerodigestive tract (UADT) carcinomas continue to
be the 5th most common cancer. Early diagnosis is often
delayed as tumour precursors or early cancers are hardly
visible and not picked up by common imaging methods.
Fluorescence spectroscopy and imaging seems able to
improve the detection and delimitation of these lesions.
Fluorescence diagnostic methods usually pick up a
"mixed bag" of signals from endogenous fluorophores
such as tryptophan, collagen, elastin, NADH and FAD. As
some of these show a tumour specific distribution, this
can be exploited to distinguish tissues in vivo. The fluores-
cence contrast is even slightly enhanced by using exoge-
nously applied fluorescent markers or their precursors
(e.g., 5-aminolevulinic acid induced Protoporphyrin IX).
Even though the sensitivity to detect malignant lesions
seems to be improved by combining fluorescence diag-
nostic methods with normal inspection according to the
literature and to our own experience, the methods are
rather unspecific as chronic inflammations cause results
similar to neoplastic disease.
Recent advances include the possibility to extract true
spectra of single fluorophores ("intrinsic spectra") by
mathematically eliminating the undesired influences of
scattering and absorption. As well, tumour-specific
enzymes are about to be specifically targeted by fluores-
cent markers (so called "smart probes") in order to
improve both sensitivity and specificity.
Due to the lack of specificity, fluorescence spectroscopy
and imaging are so far mostly feasible for screening pur-
poses. If combined with other optical techniques such as
ESS or OCT, however, a comprehensive non-invasive tis-
sue diagnosis seems possible.
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